Concepedia

Alex J. Daniels

AJ

Statistics

Publications

4

Citations

279

H-Index

4

Active since

1995

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Burroughs Wellcome Fund

Alex J. Daniels is an author at GlaxoSmithKline (United States) specializing in pharmacology, pharmacodynamics, and neuropharmacology.

Publications per year

1995–2006

4

Publications

4

High-affinity neuropeptide Y receptor antagonists.

Alex J. Daniels, Jessica Matthews, Ruta Slepetis et al. · Proceedings of the National Academy of Sciences · 1995 · 140 citations

Medicine, Neurobiology, Pharmacology +16

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

Mikhail Kalinichev, Claire Rourke, Alex J. Daniels et al. · Psychopharmacology · 2005 · 71 citations

Medicine, Endocrinology, Pharmacology +14

The discovery and optimization of pyrimidinone-containing MCH R1 antagonists

Donald L. Hertzog, Kamal Albarazanji, Eric C. Bigham et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.

Alex J. Daniels, Jessica Matthews, O. Humberto Viveros et al. · Molecular Pharmacology · 1995 · 21 citations

Medicine, Neuroscience, Pharmacology +17

1–4 of 4